Telomir Pharmaceuticals, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TELO and other ETFs, options, and stocks.About TELO
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm’s initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ.
CEOErez Aminov
CEOErez Aminov
Employees5
Employees5
HeadquartersMiami, Florida
HeadquartersMiami, Florida
Founded2021
Founded2021
Employees5
Employees5
TELO Key Statistics
Market cap49.16M
Market cap49.16M
Price-Earnings ratio-3.77
Price-Earnings ratio-3.77
Dividend yield—
Dividend yield—
Average volume284.12K
Average volume284.12K
High today$1.44
High today$1.44
Low today$1.37
Low today$1.37
Open price$1.41
Open price$1.41
Volume147.53K
Volume147.53K
52 Week high$6.88
52 Week high$6.88
52 Week low$1.12
52 Week low$1.12
Stock Snapshot
The current Telomir Pharmaceuticals, Inc.(TELO) stock price is $1.40, with a market capitalization of 49.16M. The stock trades at a price-to-earnings (P/E) ratio of -3.77.
On 2025-12-09, Telomir Pharmaceuticals, Inc.(TELO) stock moved within a range of $1.37 to $1.44. With shares now at $1.40, the stock is trading +2.2% above its intraday low and -2.8% below the session's peak.
Trading volume for Telomir Pharmaceuticals, Inc.(TELO) stock has reached 147.53K, versus its average volume of 284.12K.
The stock's 52-week range extends from a low of $1.12 to a high of $6.88.
The stock's 52-week range extends from a low of $1.12 to a high of $6.88.
People also own
Based on the portfolios of people who own TELO. This list is generated using Robinhood data, and it’s not a recommendation.